Injective News: INJ Staking ETF Filing Signals Growing Altcoin Fund Demand

Canary Capital filed with the SEC for a staked Injective ETF on Thursday.

Injective News: Canary Capital filed with the SEC for a staked Injective ETF on Thursday.

The fund would track Injective price while allowing investors to earn staking rewards from the layer-1 blockchain.

Injective's native token trades at 13.84, up 3.7% in 24 hours as the 88th-largest crypto by market cap.

21Shares already offers a staked Injective product for European investors through its AINJ ETF.

The filing reflects growing issuer interest in staking ETFs following REX-Osprey's recent Solana approval.

Canary established a Delaware Trust last month to provide a legal framework for the staked Injective product.

The fund aims to expand Injective's reach to both institutional and individual global investors.

This article contains links to third-party websites or other content for information purposes only (“Third-Party Sites”). The Third-Party Sites are not under the control of CoinMarketCap, and CoinMarketCap is not responsible for the content of any Third-Party Site, including without limitation any link contained in a Third-Party Site, or any changes or updates to a Third-Party Site. CoinMarketCap is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement, approval or recommendation by CoinMarketCap of the site or any association with its operators. This article is intended to be used and must be used for informational purposes only. It is important to do your own research and analysis before making any material decisions related to any of the products or services described. This article is not intended as, and shall not be construed as, financial advice. The views and opinions expressed in this article are the author’s [company’s] own and do not necessarily reflect those of CoinMarketCap.